Tel: | +86-21-31433387 |
+86-15618786686 | |
Email: | sales@rechemscience.com |
info@rechemscience.com | |
QQ: | 1369748377 |
Skype: | sales@rechemscience.com |
Cat.No. | Product name | Product Description |
R10097 | GNF-2 | GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no a |
R10181 | AP24534; Ponatinib | Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VE |
R10496 | Dasatinib;BMS-354825;BMS354825 | Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src |
R10503 | Nilotinib; AMN-107 | Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine m |
R10917 | Radotinib; IY-5511 | Radotinib(IY-5511) is a novel and selective BCR-ABL1 tyrosine kinase inhibitor w |
R10997 | GNF-7 | GNF-7 is a potent type-II kinase Bcr-Abl inhibitor with IC50 of <5 nM, 61 nM, |
R11633 | GZD824 (Synonyms: HQP1351) | GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(W |